FDA Circular No. 2020-0015-C || Extension of the effectivity of FDA Circular No. 2020-15, as amended, entitled “ Interim measures to vitamin drug productions during the Corona Virus disease 2019 (Covid-19) pandemic”.

Share this Post!

Attachment:-> FDA-Circular-No.2020-0015-C

Attachments